| Year |
Citation |
Score |
| 2021 |
Covés-Datson EM, King SR, Legendre M, Swanson MD, Gupta A, Claes S, Meagher JL, Boonen A, Zhang L, Kalveram B, Raglow Z, Freiberg AN, Prichard M, Stuckey JA, Schols D, ... Markovitz DM, et al. Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity. Scientific Reports. 11: 656. PMID 33436903 DOI: 10.1038/s41598-020-80577-7 |
0.662 |
|
| 2020 |
Saha AK, Contreras-Galindo R, Niknafs YS, Iyer M, Qin T, Padmanabhan K, Siddiqui J, Palande M, Wang C, Qian B, Ward E, Tang T, Tomlins SA, Gitlin SD, Sartor MA, ... ... Markovitz DM, et al. The role of the histone H3 variant CENPA in prostate cancer. The Journal of Biological Chemistry. PMID 32371391 DOI: 10.1074/Jbc.Ra119.010080 |
0.319 |
|
| 2019 |
Capitano ML, Mor-Vaknin N, Saha AK, Cooper S, Legendre M, Guo H, Contreras-Galindo R, Kappes F, Sartor MA, Lee CT, Huang X, Markovitz DM, Broxmeyer HE. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling. The Journal of Clinical Investigation. 130. PMID 31107242 DOI: 10.1172/Jci127460 |
0.397 |
|
| 2019 |
Capitano ML, Sammour Y, Legendre M, Cooper S, Markovitz D, Broxmeyer HE. Hematopoietic Stem and Progenitor Cells Manifest Direct Migration Towards Secreted DEK in a CXCR2- and G Protein Signaling-Dependent Manner Blood. 134: 1196-1196. DOI: 10.1182/Blood-2019-128738 |
0.353 |
|
| 2017 |
Contreras-Galindo RA, Dube D, Fujinaga K, Kaplan MH, Markovitz DM. Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors. Journal of Virology. PMID 28931682 DOI: 10.1128/Jvi.01309-17 |
0.38 |
|
| 2017 |
Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, ... ... Markovitz DM, et al. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nature Communications. 8: 14252. PMID 28165452 DOI: 10.1038/Ncomms14252 |
0.326 |
|
| 2016 |
Russo BC, Stamm LM, Raaben M, Kim CM, Kahoud E, Robinson LR, Bose S, Queiroz AL, Herrera BB, Baxt LA, Mor-Vaknin N, Fu Y, Molina G, Markovitz DM, Whelan SP, et al. Intermediate filaments enable pathogen docking to trigger type 3 effector translocation. Nature Microbiology. 1: 16025. PMID 27572444 DOI: 10.1038/Nmicrobiol.2016.25 |
0.306 |
|
| 2016 |
Capitano ML, Mor-Vaknin N, Legendre M, Cooper S, Markovitz D, Broxmeyer HE. DEK Regulates Hematopoietic Stem and Progenitor Cell Fate By Activating AKT and ERK Mediated Signaling through CXCR2/Heparan Sulfate Proteoglycans Blood. 128: 2645-2645. DOI: 10.1182/Blood.V128.22.2645.2645 |
0.381 |
|
| 2015 |
Swanson MD, Boudreaux DM, Salmon L, Chugh J, Winter HC, Meagher JL, André S, Murphy PV, Oscarson S, Roy R, King S, Kaplan MH, Goldstein IJ, Tarbet EB, Hurst BL, ... ... Markovitz DM, et al. Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity. Cell. 163: 746-58. PMID 26496612 DOI: 10.1016/J.Cell.2015.09.056 |
0.664 |
|
| 2015 |
Contreras-Galindo R, Kaplan MH, Dube D, Gonzalez-Hernandez MJ, Chan S, Meng F, Dai M, Omenn GS, Gitlin SD, Markovitz DM. Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences. Journal of Virology. 89: 7187-201. PMID 25926654 DOI: 10.1128/Jvi.00544-15 |
0.344 |
|
| 2015 |
Capitano ML, Mor-Vaknin N, Legendre M, Cooper S, Markovitz D, Broxmeyer HE. Recombinant DEK Enhances Ex Vivo expansion of Human Cord Blood and Mouse Bone Marrow Hematopoietic Stem Cells in a CXCR2- and Hspg-Dependent Manner Blood. 126: 779-779. DOI: 10.1182/Blood.V126.23.779.779 |
0.372 |
|
| 2014 |
Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM. Genomic flexibility of human endogenous retrovirus type K. Journal of Virology. 88: 9673-82. PMID 24920813 DOI: 10.1128/Jvi.01147-14 |
0.309 |
|
| 2014 |
Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. Journal of Virology. 88: 8924-35. PMID 24872592 DOI: 10.1128/Jvi.00556-14 |
0.396 |
|
| 2014 |
Capitano ML, Mor-Vaknin N, Legendre M, Markovitz D, Broxmeyer HE. Extracellular DEK Is a Novel Chemotactic Agent of Lineage Negative, Sca-1 Positive, c-Kit Positive Bone Marrow Cells Blood. 124: 1583-1583. DOI: 10.1182/Blood.V124.21.1583.1583 |
0.344 |
|
| 2014 |
Capitano ML, Mor-Vaknin N, Legendre M, Cooper S, Markovitz D, Broxmeyer HE. Recombinant DEK Regulates Hematopoietic Stem and Progenitor Cells in a CXCR2- GαI Protein-Dependent Manner Blood. 124: 1582-1582. DOI: 10.1182/Blood.V124.21.1582.1582 |
0.349 |
|
| 2014 |
Kaplan M, Contreras-Galindo R, Zahn J, Gitlin S, Kaminski M, Markovitz D. E-105 Human Endogenous Retroviruses in our Centromeres-Implications for Mycoses Fungoides and HIV Jaids Journal of Acquired Immune Deficiency Syndromes. 67: 61. DOI: 10.1097/01.Qai.0000456115.59806.E6 |
0.387 |
|
| 2014 |
Chan J, Chan K, Boudreaux D, Swanson M, Markovitz D, Yuen K. 1159BanLec, a banana lectin, is a potent inhibitor of Middle East respiratory syndrome coronavirus in in vitro assays Open Forum Infectious Diseases. 1: S344-S344. DOI: 10.1093/Ofid/Ofu052.867 |
0.623 |
|
| 2013 |
Broxmeyer HE, Mor-Vaknin N, Kappes F, Legendre M, Saha AK, Ou X, O'Leary H, Capitano M, Cooper S, Markovitz DM. Concise review: role of DEK in stem/progenitor cell biology. Stem Cells (Dayton, Ohio). 31: 1447-53. PMID 23733396 DOI: 10.1002/Stem.1443 |
0.358 |
|
| 2013 |
Contreras-Galindo R, Kaplan MH, He S, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Kappes F, Dube D, Chan SM, Robinson D, Meng F, Dai M, Gitlin SD, Chinnaiyan AM, Omenn GS, Markovitz DM. HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses. Genome Research. 23: 1505-13. PMID 23657884 DOI: 10.1101/Gr.144303.112 |
0.347 |
|
| 2013 |
Saha AK, Kappes F, Mundade A, Deutzmann A, Rosmarin DM, Legendre M, Chatain N, Al-Obaidi Z, Adams BS, Ploegh HL, Ferrando-May E, Mor-Vaknin N, Markovitz DM. Intercellular trafficking of the nuclear oncoprotein DEK. Proceedings of the National Academy of Sciences of the United States of America. 110: 6847-52. PMID 23569252 DOI: 10.1073/Pnas.1220751110 |
0.375 |
|
| 2013 |
Mor-Vaknin N, Legendre M, Yu Y, Serezani CH, Garg SK, Jatzek A, Swanson MD, Gonzalez-Hernandez MJ, Teitz-Tennenbaum S, Punturieri A, Engleberg NC, Banerjee R, Peters-Golden M, Kao JY, Markovitz DM. Murine colitis is mediated by vimentin. Scientific Reports. 3: 1045. PMID 23304436 DOI: 10.1038/Srep01045 |
0.641 |
|
| 2012 |
Monde K, Contreras-Galindo R, Kaplan MH, Markovitz DM, Ono A. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. Journal of Virology. 86: 11194-208. PMID 22855497 DOI: 10.1128/Jvi.00301-12 |
0.413 |
|
| 2012 |
Férir G, Huskens D, Palmer KE, Boudreaux DM, Swanson MD, Markovitz DM, Balzarini J, Schols D. Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains. Aids Research and Human Retroviruses. 28: 1513-23. PMID 22607556 DOI: 10.1089/Aid.2012.0026 |
0.707 |
|
| 2012 |
Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ, Kaplan MH, Markovitz DM. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. Journal of Virology. 86: 7790-805. PMID 22593154 DOI: 10.1128/Jvi.07215-11 |
0.739 |
|
| 2012 |
Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. Journal of Virology. 86: 262-76. PMID 22031938 DOI: 10.1128/Jvi.00602-11 |
0.37 |
|
| 2012 |
Broxmeyer HE, Kappes F, Mor-Vaknin N, Legendre M, Kinzfogl J, Cooper S, Hangoc G, Markovitz DM. DEK regulates hematopoietic stem engraftment and progenitor cell proliferation. Stem Cells and Development. 21: 1449-54. PMID 21943234 DOI: 10.1182/Blood.V118.21.1275.1275 |
0.327 |
|
| 2012 |
Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo RA, Cookinham S, Noel RJ, Kaplan MH, Markovitz DM. D4 Expression of Human Endogenous Retrovirus Type-K (HML-2) is Activated by the Tat Protein of HIV-1 Journal of Acquired Immune Deficiency Syndromes. 59: 80. DOI: 10.1097/01.Qai.0000413803.10146.5F |
0.707 |
|
| 2011 |
Stelzer AC, Frank AT, Kratz JD, Swanson MD, Gonzalez-Hernandez MJ, Lee J, Andricioaei I, Markovitz DM, Al-Hashimi HM. Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nature Chemical Biology. 7: 553-9. PMID 21706033 DOI: 10.1038/Nchembio.596 |
0.709 |
|
| 2011 |
Férir G, Vermeire K, Huskens D, Balzarini J, Van Damme EJ, Kehr JC, Dittmann E, Swanson MD, Markovitz DM, Schols D. Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). Antiviral Research. 90: 200-4. PMID 21501631 DOI: 10.1016/J.Antiviral.2011.03.188 |
0.712 |
|
| 2011 |
Kappes F, Waldmann T, Mathew V, Yu J, Zhang L, Khodadoust MS, Chinnaiyan AM, Luger K, Erhardt S, Schneider R, Markovitz DM. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes & Development. 25: 673-8. PMID 21460035 DOI: 10.1101/Gad.2036411 |
0.643 |
|
| 2011 |
Kappes F, Khodadoust MS, Yu L, Kim DS, Fullen DR, Markovitz DM, Ma L. DEK expression in melanocytic lesions. Human Pathology. 42: 932-8. PMID 21316078 DOI: 10.1016/J.Humpath.2010.10.022 |
0.579 |
|
| 2011 |
Mor-Vaknin N, Kappes F, Dick AE, Legendre M, Damoc C, Teitz-Tennenbaum S, Kwok R, Ferrando-May E, Adams BS, Markovitz DM. DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis and Rheumatism. 63: 556-67. PMID 21280010 DOI: 10.1002/Art.30138 |
0.303 |
|
| 2011 |
Contreras-Galindo R, Kaplan MH, Gonzalez-Hernandez M, Markovitz DM. 223 The Newly-Discovered Human Endogenous Retrovirus HERV-K 111 is Transcriptionally-Active Only Upon HIV Infection Jaids Journal of Acquired Immune Deficiency Syndromes. 56: 96. DOI: 10.1097/01.Qai.0000397405.29781.5F |
0.399 |
|
| 2011 |
Kaplan MH, Contreras-Galindo R, Gonzalez-Hernandez M, Gitlin SD, Dosik MH, Markovitz D. 183 HIV Exposes Major “Trafficking” in HERV- K HML-2 Viruses Which are Critical to the Pathogenesis of HIV Infection and Lymphoma Jaids Journal of Acquired Immune Deficiency Syndromes. 56: 76. DOI: 10.1097/01.Qai.0000397365.84039.Ce |
0.405 |
|
| 2010 |
Fahrer J, Popp O, Malanga M, Beneke S, Markovitz DM, Ferrando-May E, Bürkle A, Kappes F. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length. Biochemistry. 49: 7119-30. PMID 20669926 DOI: 10.1021/Bi1004365 |
0.343 |
|
| 2010 |
Swanson MD, Winter HC, Goldstein IJ, Markovitz DM. A lectin isolated from bananas is a potent inhibitor of HIV replication. The Journal of Biological Chemistry. 285: 8646-55. PMID 20080975 DOI: 10.1074/Jbc.M109.034926 |
0.729 |
|
| 2009 |
Khodadoust MS, Verhaegen M, Kappes F, Riveiro-Falkenbach E, Cigudosa JC, Kim DS, Chinnaiyan AM, Markovitz DM, Soengas MS. Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Research. 69: 6405-13. PMID 19679545 DOI: 10.1158/0008-5472.Can-09-1063 |
0.627 |
|
| 2008 |
Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Bürkle A, Markovitz DM, Ferrando-May E. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Molecular and Cellular Biology. 28: 3245-57. PMID 18332104 DOI: 10.1128/Mcb.01921-07 |
0.631 |
|
| 2008 |
Devany M, Kappes F, Chen KM, Markovitz DM, Matsuo H. Solution NMR structure of the N-terminal domain of the human DEK protein. Protein Science : a Publication of the Protein Society. 17: 205-15. PMID 18227428 DOI: 10.1110/Ps.073244108 |
0.344 |
|
| 2008 |
Gitlin SD, Galindo RC, Kaplan MH, Markovitz DM. Role of Human Endogenous Retroviruses in Lymphoma Pathogenesis and a Possible Biomarker of Disease Blood. 112: 3751-3751. DOI: 10.1182/Blood.V112.11.3751.3751 |
0.382 |
|
| 2007 |
Bargagna-Mohan P, Hamza A, Kim YE, Khuan Abby Ho Y, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan CG, Kim KB, Mohan R. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chemistry & Biology. 14: 623-34. PMID 17584610 DOI: 10.1016/J.Chembiol.2007.04.010 |
0.335 |
|
| 2006 |
Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. Aids Research and Human Retroviruses. 22: 979-84. PMID 17067267 DOI: 10.1089/Aid.2006.22.979 |
0.366 |
|
| 2006 |
Mor-Vaknin N, Punturieri A, Sitwala K, Faulkner N, Legendre M, Khodadoust MS, Kappes F, Ruth JH, Koch A, Glass D, Petruzzelli L, Adams BS, Markovitz DM. The DEK nuclear autoantigen is a secreted chemotactic factor. Molecular and Cellular Biology. 26: 9484-96. PMID 17030615 DOI: 10.1128/Mcb.01030-06 |
0.74 |
|
| 2005 |
Cleary J, Sitwala KV, Khodadoust MS, Kwok RP, Mor-Vaknin N, Cebrat M, Cole PA, Markovitz DM. p300/CBP-associated factor drives DEK into interchromatin granule clusters. The Journal of Biological Chemistry. 280: 31760-7. PMID 15987677 DOI: 10.1074/Jbc.M500884200 |
0.768 |
|
| 2003 |
Sitwala KV, Mor-Vaknin N, Markovitz DM. Minireview: DEK and gene regulation, oncogenesis and AIDS. Anticancer Research. 23: 2155-8. PMID 12894590 |
0.726 |
|
| 2003 |
Adams BS, Cha HC, Cleary J, Haiying T, Wang H, Sitwala K, Markovitz DM. DEK binding to class II MHC Y-box sequences is gene- and allele-specific. Arthritis Research & Therapy. 5: R226-33. PMID 12823858 DOI: 10.1186/Ar774 |
0.737 |
|
| 2003 |
Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM. The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology. 307: 122-34. PMID 12667820 DOI: 10.1016/S0042-6822(02)00045-4 |
0.604 |
|
| 2003 |
Faulkner NE, Lane BR, Bock PJ, Markovitz DM. Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. Journal of Virology. 77: 2276-81. PMID 12525665 DOI: 10.1128/Jvi.77.3.2276-2281.2003 |
0.802 |
|
| 2003 |
Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. Vimentin is secreted by activated macrophages. Nature Cell Biology. 5: 59-63. PMID 12483219 DOI: 10.1038/Ncb898 |
0.749 |
|
| 2002 |
Sitwala KV, Adams K, Markovitz DM. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene. 21: 8862-70. PMID 12483538 DOI: 10.1038/Sj.Onc.1206041 |
0.765 |
|
| 2002 |
Lane BR, Liu J, Bock PJ, Schols D, Coffey MJ, Strieter RM, Polverini PJ, Markovitz DM. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. Journal of Virology. 76: 11570-83. PMID 12388718 DOI: 10.1128/Jvi.76.22.11570-11583.2002 |
0.559 |
|
| 2002 |
Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cellular Immunology. 215: 61-71. PMID 12142037 DOI: 10.1016/S0008-8749(02)00017-5 |
0.611 |
|
| 2002 |
Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. The Journal of Biological Chemistry. 277: 16913-9. PMID 11847231 DOI: 10.1074/Jbc.M200875200 |
0.612 |
|
| 2001 |
Bock PJ, Markovitz DM. Infection with hiv-2 Aids. 15. PMID 11816173 DOI: 10.1097/00002030-200100005-00006 |
0.411 |
|
| 2001 |
Lane BR, Lore K, Bock PJ, Andersson J, Coffey MJ, Strieter RM, Markovitz DM. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. Journal of Virology. 75: 8195-202. PMID 11483765 DOI: 10.1128/Jvi.75.17.8195-8202.2001 |
0.569 |
|
| 2001 |
Lane BR, Strieter RM, Coffey MJ, Markovitz DM. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. Journal of Virology. 75: 5812-22. PMID 11390582 DOI: 10.1128/Jvi.75.13.5812-5822.2001 |
0.579 |
|
| 2001 |
Faulkner NE, Hilfinger JM, Markovitz DM. Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site. The Journal of Biological Chemistry. 276: 25804-12. PMID 11320078 DOI: 10.1074/Jbc.M006454200 |
0.798 |
|
| 2001 |
Browning CM, Smith MJ, Clark NM, Lane BR, Parada C, Montano M, KewalRamani VN, Littman DR, Essex M, Roeder RG, Markovitz DM. Human GLI-2 is a tat activation response element-independent Tat cofactor. Journal of Virology. 75: 2314-23. PMID 11160734 DOI: 10.1128/Jvi.75.5.2314-2323.2001 |
0.625 |
|
| 2001 |
Smith MJ, Gitlin SD, Browning CM, Lane BR, Clark NM, Shah N, Rainier S, Markovitz DM. GLI-2 modulates retroviral gene expression. Journal of Virology. 75: 2301-13. PMID 11160733 DOI: 10.1128/Jvi.75.5.2301-2313.2001 |
0.618 |
|
| 1999 |
Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. Journal of Immunology (Baltimore, Md. : 1950). 163: 3653-61. PMID 10490959 |
0.508 |
|
| 1999 |
Browning CM, Cagnon L, Good PD, Rossi J, Engelke DR, Markovitz DM. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 Tat activation-response RNA decoy Journal of Virology. 73: 5191-5195. PMID 10233987 DOI: 10.1128/Jvi.73.6.5191-5195.1999 |
0.46 |
|
| 1998 |
Fu GK, Markovitz DM. The human LON protease binds to mitochondrial promoters in a single- stranded, site-specific, strand-specific manner Biochemistry. 37: 1905-1909. PMID 9485316 DOI: 10.1021/Bi970928C |
0.353 |
|
| 1997 |
Browning C, Hilfinger JM, Rainier S, Lin V, Hedderwick S, Smith M, Markovitz DM. The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation Journal of Virology. 71: 8048-8055. PMID 9311903 DOI: 10.1128/Jvi.71.10.8048-8055.1997 |
0.482 |
|
| 1997 |
Coffey MJ, Woffendin C, Phare SM, Strieter RM, Markovitz DM. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. The American Journal of Physiology. 272: L1025-9. PMID 9176270 DOI: 10.1152/Ajplung.1997.272.5.L1025 |
0.446 |
|
| 1997 |
Fu GK, Grosveld G, Markovitz DM. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer Proceedings of the National Academy of Sciences of the United States of America. 94: 1811-1815. PMID 9050861 DOI: 10.1073/Pnas.94.5.1811 |
0.464 |
|
| 1997 |
Fu GK, Smith MJ, Markovitz DM. Bacterial protease Lon is a site-specific DNA-binding protein Journal of Biological Chemistry. 272: 534-538. PMID 8995294 DOI: 10.1074/Jbc.272.1.534 |
0.363 |
|
| 1996 |
Fu GK, Markovitz DM. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer Journal of Biological Chemistry. 271: 19599-19605. PMID 8702655 DOI: 10.1074/Jbc.271.32.19599 |
0.461 |
|
| 1995 |
Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, Krutchkoff DJ, Felix DH, Raab-Traub N. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. The Journal of Infectious Diseases. 171: 1122-30. PMID 7751686 DOI: 10.1093/Infdis/171.5.1122 |
0.351 |
|
| 1995 |
Clark NM, Hannibal MC, Markovitz DM. The peri-κB site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells Journal of Virology. 69: 4854-4862. PMID 7609053 DOI: 10.1128/Jvi.69.8.4854-4862.1995 |
0.486 |
|
| 1994 |
Hannibal MC, Markovitz DM, Nabel GJ. Multiple cis-acting elements in the human immunodeficiency virus type 2 enhancer mediate the response to T-cell receptor stimulation by antigen in a T-cell hybridoma line Blood. 83: 1839-1846. PMID 8142652 DOI: 10.1182/Blood.V83.7.1839.Bloodjournal8371839 |
0.448 |
|
| 1993 |
Hilfinger JM, Clark N, Smith M, Robinson K, Markovitz DM. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation Journal of Virology. 67: 4448-4453. PMID 8510231 DOI: 10.1128/Jvi.67.7.4448-4453.1993 |
0.478 |
|
| 1993 |
Markovitz DM. Infection with the human immunodeficiency virus type 2 Annals of Internal Medicine. 118: 211-218. PMID 8380244 DOI: 10.1016/0020-7292(93)90242-O |
0.416 |
|
| 1993 |
Clark NM, Smith MJ, Hilfinger JM, Markovitz DM. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor Journal of Virology. 67: 5522-5528. PMID 8350410 DOI: 10.1128/Jvi.67.9.5522-5528.1993 |
0.384 |
|
| 1993 |
Hannibal MC, Markovitz DM, Clark N, Nabel GJ. Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals Journal of Virology. 67: 5035-5040. PMID 8331739 DOI: 10.1128/Jvi.67.8.5035-5040.1993 |
0.461 |
|
| 1992 |
Markovitz DM, Hannibal MC, Smith MJ, Cossman R, Nabel GJ. Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1 Journal of Virology. 66: 3961-3965. PMID 1533884 DOI: 10.1128/Jvi.66.6.3961-3965.1992 |
0.362 |
|
| 1992 |
Leiden JM, Wang CY, Petryniak B, Markovitz DM, Nabel GJ, Thompson CB. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. Journal of Virology. 66: 5890-7. PMID 1527846 DOI: 10.1128/Jvi.66.10.5890-5897.1992 |
0.487 |
|
| 1992 |
Markovitz DM, Smith MJ, Hilfinger J, Hannibal MC, Petryniak B, Nabel GJ. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and κB regulatory elements Journal of Virology. 66: 5479-5484. PMID 1501284 DOI: 10.1128/Jvi.66.9.5479-5484.1992 |
0.466 |
|
| 1990 |
Markovitz DM, Hannibal M, Perez VL, Gauntt C, Folks TM, Nabel GJ. Differential regulation of human immunodeficiency viruses (HIVs): A specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor Proceedings of the National Academy of Sciences of the United States of America. 87: 9098-9102. PMID 2147512 DOI: 10.1073/Pnas.87.23.9098 |
0.468 |
|
| 1986 |
Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection Science. 233: 215-219. PMID 3014648 DOI: 10.1126/Science.3014648 |
0.304 |
|
| Show low-probability matches. |